David Stump
Direktor/Vorstandsmitglied bei MACROGENICS, INC.
Vermögen: 48 341 $ am 30.04.2024
Aktive Positionen von David Stump
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MACROGENICS, INC. | Direktor/Vorstandsmitglied | 19.09.2013 | - |
Independent Dir/Board Member | 19.09.2013 | - | |
REGENXBIO INC. | Direktor/Vorstandsmitglied | 15.10.2015 | - |
Independent Dir/Board Member | 15.10.2015 | - | |
Earlham College | Direktor/Vorstandsmitglied | 22.02.2010 | - |
Karriereverlauf von David Stump
Ehemalige bekannte Positionen von David Stump
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VIRACTA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.06.2006 | 24.02.2021 |
Independent Dir/Board Member | 01.06.2006 | 24.02.2021 | |
DENDREON CORPORATION | Direktor/Vorstandsmitglied | 02.06.2010 | 10.06.2015 |
Independent Dir/Board Member | 06.12.2011 | 10.06.2015 | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.1999 | 01.12.2012 |
Adventist HealthCare, Inc.
Adventist HealthCare, Inc. Medical/Nursing ServicesHealth Services Adventist HealthCare, Inc. engages in the provision of health care services. It offers bariatric surgery, behavioral health, cardiology, chronic wound care, cancer care, pediatrics, radiology, rehabilitation, senior living and home health care services. The company was founded in 1907 and is headquartered in Gaithersburg, MD. | Direktor/Vorstandsmitglied | - | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1989 | 01.01.1999 |
PORTOLA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 24.09.2015 | - |
Independent Dir/Board Member | 24.09.2015 | - | |
░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von David Stump
Earlham College | Undergraduate Degree |
Indiana University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Operativ
Director/Board Member | 7 |
Independent Dir/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 4 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MACROGENICS, INC. | Health Technology |
REGENXBIO INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Adventist HealthCare, Inc.
Adventist HealthCare, Inc. Medical/Nursing ServicesHealth Services Adventist HealthCare, Inc. engages in the provision of health care services. It offers bariatric surgery, behavioral health, cardiology, chronic wound care, cancer care, pediatrics, radiology, rehabilitation, senior living and home health care services. The company was founded in 1907 and is headquartered in Gaithersburg, MD. | Health Services |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- David Stump
- Erfahrung